Laboratory Corporation of America Holdings

• Country

  United States of America

• Sector

  Health Care

• Industry group

  Health Care Equipment & Services

• Industry

  Health Care Providers & Services

• Sub-sector

  Health Care

• Capitalization (millions of $)

  17307.2

• Ticker

  LH.N

• ISIN

  US50540R4092

• IPO date

  1991-04-24

• Availability on Russian exchanges

  Yes

• Reporting for

  2024-02-26

• Date fact. publication of reports

  2023-12-31

Laboratory Corporation of America Holdings is a life sciences company that provides clinical laboratory and end-to-end drug development services. The Company’s business segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). Through its Dx and DD segments, the Company provides diagnostic, drug development and technology enabled solutions. The Company also supports clinical trial activity in approximately 100 countries through its industry central laboratory, preclinical, and clinical development businesses. Dx segment operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. DD segment, which operates on a global scale. The Company serves a range of customers, including doctors, hospitals, pharmaceutical companies, researchers, governmental agencies, physicians and other healthcare providers. It also helps in delivering non-clinical testing services.